Otitis Externa

Last updated: November 15, 2024

Otitis Externa

Otitis externa is infection (cellulitis) of the external auditory canal. It is classically associated with swimming. The most common cause is bacterial infection. The most common pathogen is Pseudomonas aeruginosa. Diagnosis is clinical. Investigations for otitis externa are only carried out if there is recurrent or treatment resistant otitis externa, or immunocompromised state. If otitis externa is recurrent, rule out diabetes and chronic underlying infection of the nasal passages which might be spread to the ears by the patient’s fingers.

Classification of otitis externa

ClassificationExamples
InfectiousLocalised acute otitis externa (furuncle), diffuse acute otitis externa, otomycosis, herpes zoster oticus, otitis externa hemorrhagica
ReactiveEczematous otitis externa, seborrhoeic otitis externa, neurodermatitis
  • Causes
    • Bacterial infections (the most common cause; common organisms include Pseudomonas aeruginosa, Staphylococcus aureus)
    • Fungal infection (Otomycosis – Aspergillus nigerA. fumigatus or Candida albicans. )
    • Viral infection (Herpes zoster oticus)
    • Allergies
    • Eczema
    • Psoriasis
  • Risk factors
    • Swimming
    • Humidity
    • Ear canal obstruction (cerumen impaction)
    • Trauma (ear devices)
    • Narrow ear canals
    • Radiotherapy and chemotherapy
    • Stress
    • Immunocompromised states
  • Signs and symptoms
    • Ear Pain (especially with manipulation of the ear)
    • Itching of the external auditory canal
    • Draining of the external auditory canal
    • Sensation of fullness
    • Decreased hearing
    • Cervical lymphadenopathy
    • Pain on moving the jaw
  • Otoscopic examination
    • Erythematous and oedematous ear canal with debris
    • Tympanic membrane may be difficult to visualize through the swollen ear canal (makes it difficult to rule out concomitant otitis media)
    • Fungal mass on otoscopic examination in case of otomycosis
  • Treatment
    • Aural toilet and incision and drainage if an abscess has formed
    • Topical antibiotics and steroid preparation
      • Polymyxin B, neomycin, and hydrocortisone 3 to 4 drops to the affected ear four times a day.
      • Ofloxacin 5 drops to the affected ear twice daily
      • Ciprofloxacin with hydrocortisone 3 drops to the affected ear twice daily
    • Analgesia – acetaminophen, NSAIDs
    In cases with marked edema, an ear wick will be needed to facilitate medication delivery.

Malignant Otitis Externa

Malignant otitis externa is a life-threatening osteomyelitis of the skull base. It should be considered if simple otitis externa does not respond to antibiotics. It involves the external ear canal, temporal bone and skull base.

  • Risk factors
    • Diabetes
    • Elderly
    • Male
    • Immunocompromised – chemotherapy, HIV, malignancy
    • Persistent otitis externa
  • Common microorganisms
    • Pseudomonas aeruginosa – most common
    • Proteus spp
    • Klebsiella spp
    • Staphylococcus aureus, with an increasing presence of methicillin-resistant S aureus (MRSA) strains
    • S epidermidis
    • Aspergillus spp
    • Candida spp
  • Investigations
    • CT/MRI: best initial test
    • Bone biopsy: most accurate test
  • Complications
    • Cranial nerve palsies
    • Brain abscess
    • Meningitis
    • venous sinus thrombosis
  • Treatment
    • IV Ciprofloxacin → PO Ciprofloxacin
      • Topical drops
Reference Intervals
Biochemistry
ACTHP: <80 ng/L
ALTP: 5–35 U/L
AlbuminP: 35–50 g/L
AldosteroneP: 100–500 pmol/L
Alk. phosphataseP: 30–130 U/L
α-AmylaseP: 0–180 IU/dL
α-FetoproteinS: <10 kU/L
Angiotensin IIP: 5–35 pmol/L
ADHP: 0.9–4.6 pmol/L
ASTP: 5–35 U/L
BicarbonateP: 24–30 mmol/L
BilirubinP: 3–17 μmol/L
BNPP: <50 ng/L
CRPP: <10 mg/L
CalcitoninP: <0.1 mcg/L
Calcium (ionized)P: 1.0–1.25 mmol/L
Calcium (total)P: 2.12–2.60 mmol/L
ChlorideP: 95–105 mmol/L
CholesterolP: <5.0 mmol/L
VLDLP: 0.128–0.645 mmol/L
LDLP: <2.0 mmol/L
HDLP: 0.9–1.93 mmol/L
Cortisol AMP: 450–700 nmol/L
Cortisol MidnightP: 80–280 nmol/L
CK ♂P: 25–195 U/L
CK ♀P: 25–170 U/L
CreatinineP: 70–100 μmol/L
FerritinP: 12–200 mcg/L
FolateS: 2.1 mcg/L
FSHP: 2–8 U/L ♂; >25 menopause
GGT ♂P: 11–51 U/L
GGT ♀P: 7–33 U/L
Glucose (fasting)P: 3.5–5.5 mmol/L
Growth hormoneP: <20 mu/L
HbA1C (DCCT)B: 4–6%
HbA1C (IFCC)B: 20–42 mmol/mol
Iron ♂S: 14–31 μmol/L
Iron ♀S: 11–30 μmol/L
Lactate (venous)P: 0.6–2.4 mmol/L
Lactate (arterial)P: 0.6–1.8 mmol/L
LDHP: 70–250 U/L
LHP: 3–16 U/L
MagnesiumP: 0.75–1.05 mmol/L
OsmolalityP: 278–305 mosmol/kg
PTHP: 0.8–8.5 pmol/L
PotassiumP: 3.5–5.3 mmol/L
Prolactin ♂P: <450 U/L
Prolactin ♀P: <600 U/L
PSAP: 0–4 mcg/mL
Protein (total)P: 60–80 g/L
Red cell folateB: 0.36–1.44 μmol/L
Renin (erect)P: 2.8–4.5 pmol/mL/h
Renin (recumbent)P: 1.1–2.7 pmol/mL/h
SodiumP: 135–145 mmol/L
TBGP: 7–17 mg/L
TSHP: 0.5–4.2 mU/L
T4P: 70–140 nmol/L
Free T4P: 9–22 pmol/L
TIBCS: 54–75 μmol/L
TriglyceridesP: 0.50–2.3 mmol/L
T3P: 1.2–3.0 nmol/L
Troponin TP: <0.1 mcg/L
Urate ♂P: 210–480 μmol/L
Urate ♀P: 150–390 μmol/L
UreaP: 2.5–6.7 mmol/L
Vitamin B12S: 0.13–0.68 nmol/L
Vitamin DS: 50 nmol/L
Arterial Blood Gases
pH7.35–7.45
PaCO₂4.7–6.0 kPa
PaO₂>10.6 kPa
Base excess±2 mmol/L
Urine
Cortisol (free)<280 nmol/24h
Hydroxyindole acetic acid16–73 μmol/24h
Hydroxymethylmandelic acid16–48 μmol/24h
Metanephrines0.03–0.69 μmol/mmol cr.
Osmolality350–1000 mosmol/kg
17-Oxogenic steroids ♂28–30 μmol/24h
17-Oxogenic steroids ♀21–66 μmol/24h
17-Oxosteroids ♂17–76 μmol/24h
17-Oxosteroids ♀14–59 μmol/24h
Phosphate (inorganic)15–50 mmol/24h
Potassium14–120 mmol/24h
Protein<150 mg/24h
Protein/creatinine ratio<3 mg/mmol
Sodium100–250 mmol/24h
Haematology
WCC4.0–11.0 ×10⁹/L
RBC ♂4.5–6.5 ×10¹²/L
RBC ♀3.9–5.6 ×10¹²/L
Hb ♂130–180 g/L
Hb ♀115–160 g/L
PCV ♂0.4–0.54 L/L
PCV ♀0.37–0.47 L/L
MCV76–96 fL
MCH27–32 pg
MCHC300–360 g/L
RDW11.6–14.6%
Neutrophils2.0–7.5 ×10⁹/L (40–75%)
Lymphocytes1.0–4.5 ×10⁹/L (20–45%)
Eosinophils0.04–0.44 ×10⁹/L (1–6%)
Basophils0–0.10 ×10⁹/L (0–1%)
Monocytes0.2–0.8 ×10⁹/L (2–10%)
Platelets150–400 ×10⁹/L
Reticulocytes0.8–2.0% / 25–100 ×10⁹/L
Prothrombin time10–14 s
APTT35–45 s
Paediatric
Pulse Rate (bpm)
Neonate140–160
Infant <1yr120–140
1–5 years110–130
5–12 years80–120
>12 years70–100
Respiratory Rate (tachypnoea)
0–2 months≥60/min
2–12 months≥50/min
1–5 years≥40/min
>5 years≥30/min
Blood Pressure (mmHg)
Term65/45
1 year75/50
4 years85/60
8 years95/65
10 years100/70
Weight Formulas
3–12 months(a + 9)/2 kg
1–6 years2a + 8 kg
>6 years(7a − 5)/2 kg
Haemoglobin (g/dL)
Term newborn13–20
1 month11–18
2 months10–15
1–2 years10–13
>2 years11–14
MUAC (6 months–5 years)
Obese>17.5 cm
Normal13.5–17.4 cm
At risk12.5–13.4 cm
Moderate malnutrition11.5–12.4 cm
Severe malnutrition<11.5 cm
Developmental Milestones
Social smile1.5 months
Head control4 months
Sits unsupported7 months
Crawls10 months
Stands unsupported10–12 months
Walks12–13 months
Talks18 months
CSF WBC (/mm³)
Term newborn0–25
>2 weeks0–5
Calculator

Post Discussion

Your email address will not be published. Required fields are marked *